Future perfect: GSK, Alphabet create Galvani to cure arthiritis, diabetes
GlaxoSmithKline, the U.K.’s biggest drugmaker, has created a £540m joint venture called Galvani with Google parent Alphabet’s life-sciences business to research and develop bioelectronic medicines.